Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001241682 | SCV001414716 | uncertain significance | Jeune thoracic dystrophy | 2022-11-29 | criteria provided, single submitter | clinical testing | Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Not Available"). This variant has not been reported in the literature in individuals affected with IFT80-related conditions. This variant, c.239_250delinsGGGTTT, is a complex sequence change that results in the deletion of 5 and insertion of 3 amino acid(s) in the IFT80 protein (p.Phe80_Ser84delinsTrpValCys). |
Fulgent Genetics, |
RCV005029820 | SCV005657938 | uncertain significance | Asphyxiating thoracic dystrophy 2 | 2024-06-15 | criteria provided, single submitter | clinical testing |